Oixd The Prepaid Card Carves A Niche In The B2B Payments Ecosystem
Peoples Financial Services Corp.聽and FNCB Bancorp聽have received shareholder approval for their previously announced plans to merge.This approval was g
stanley tumblers iven Friday March 22 at special meetings of the companies respective shareholders, Peoples and FNCB said in a Friday press release.The closing of the proposed merger remains subject to regulatory approvals and other customary closing conditions, according to the release.In their Friday votes, the shareholders approved the merger of FNCB with and into Peoples, with Peoples being the surviving corporation, as detailed in a Sept. 27 merger plan, the release said.Peoples is the bank holding company of Peoples Security Bank and Trust Company, an independent community bank with 28 full-service branches in Pennsylvania, New Jersey and New York, per the release.FNCB Bancorp is the bank holding company of FNCB Bank, which is a community bank with 16 branches in Northeastern Pennsylvania, according to the Friday press release.The compa
stanley romania nies announced in September that they had entered into a definitive agreement to merge, saying in a press release聽that the combination would create a bank holding company with nearly $5.5 billion聽in assets and a combined market capitalization of about $444 million. This strategic merger accelerates our objective of creating a dynamic, top-tier Pennsylvania franc
stanley italy hise in order to help our communities become a better place to live and work while offering the best services possible to our customers, Peoples C Ivjp Uber Looks To Buy AI Startup For Self-Driving Tech
In the latest accounting scandal to hit a major global corporation, Samsungs biotech unit, Samsung BioLogics, suffered a $6 billion market value loss on Wednesday May 2 after South Koreas financial regulator revealed evidence the company violated accounting rules, according to Reuters reports.Shares in the company dropped by nearly 20 percent after revelations by the Financial Supervisory Service FSS . The watchdog said earlier in the week that it issued a preliminary notice to Samsung BioLogics and its auditors of possible action in response to suspicions that the company inflated net profits ahead
stanley france of its 2016 initial public offering IPO .At the time, the companys float was South Koreas second-largest share sale, earlier Reuters reports said.According to the publication, the FSS did not go i
stanley termos nto details about the allegations of accounting misconduct. But Samsung BioLogics has denied the accusations and said in an emergency press conference that it is considering filing a lawsuit against the regulator. If a decision is made that we cannot accept,
stanley cup we plan to file an administrative lawsuit, the companys Vice President Byunghwa Shim said in a statement during the press event. The company vowed to prove it adhered to accounting rules.Earlier this year, the head of the FSS, Choe Heung-sik, stepped down following revelations of a hiring scandal while serving as president of the Hana Financial Group. Those revelations emerged as the FSS began an investigation of unfair hiring pr